March 10, 2026 Rapid Novor Inc., a Canadian biotechnology leader, announced today that its diagnostic laboratory has received a provisional license from the Ontario Ministry of Health (MOH) for its EasyM® assay, enabling the company to begin testing patients in Canada. This milestone represents the first time highly sensitive measurable residual disease (MRD) monitoring [...]
Newly published research has identified antibodies capable of preventing malaria, discovered in the blood of a 9-year-old Tanzanian child with previous exposure to the disease. By sequencing antibodies from the child’s blood, researchers identified antibodies that block a critical interaction between the malaria-causing parasite and human blood vessels. Published in PNAS, the study [...]
We are proud to be part of a newly published peer-reviewed study in Nature Communications. By combining PASEF-enabled mass spectrometry with de novo protein sequencing, the team greatly improved sensitivity and detection in complex microbiomes. The approach introduces the concept of a "druggable metaproteome", offering a new framework to advance microbiome research and develop [...]
Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb® antibody discovery platform was used to sequence a complex mixture of functional antibodies directly from the serum of a human patient after receiving a COVID-19 vaccine. Titled “De Novo Protein Sequencing of Antibodies for Identification [...]
A Canadian Multiple Myeloma (MM) clinical trial sponsored by Rapid Novor, has enrolled its first patient. This is the first Canadian prospective clinical study aiming to evaluate the EasyM™ assay (mass spectrometry measurement of a myeloma biomarker) for disease response in newly diagnosed MM patients (NDMM) receiving standard of care treatment. A clinical [...]
Rapid Novor Inc and MAbSilico announced that they have partnered to provide the world’s first AI-driven HDX-MS epitope mapping service for antibody development. By seamlessly integrating experimental data from HDX-MS with predictive analytics derived from AI-driven computational modeling, researchers can gain a comprehensive understanding of antibody structure, dynamics, and interactions with unparalleled precision and [...]
Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its REpAb® antibody discovery platform was used to successfully sequence a complex mixture of functional antibodies directly from the serum of a human patient after receiving a COVID-19 vaccine. “This demonstrates a significant breakthrough in antibody discovery technology [...]
Rapid Novor’s Blood Test for Multiple Myeloma Monitoring is CLIA Certified for Clinical Use in the US Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its diagnostic laboratory obtained the Clinical Laboratory Improvement Amendments (CLIA) certification for their EasyM™ assay as a Laboratory Developed Test (LDT). [...]
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in collaboration with Rapid Novor Inc., using over 1.7 million PASEF data-points to improve accuracy [...]
Alpaca Serum Antibodies Decoded with Rapid Novor’s De Novo Protein Sequencing Technology Rapid Novor Inc., the world's leader in antibody protein sequencing using mass spectrometry, announced today that its REpAb® antibody discovery platform was used to successfully sequence 10 unique nanobodies directly from an alpaca’s serum polyclonal antibody proteins. Furthermore, the 10 nanobodies were recombinantly [...]
Rapid Novor First to Decode Polyclonal Antibodies Using Only Proteomics Rapid Novor Inc., the world's leader in antibody protein sequencing using mass spectrometry, announced today that it has reached a major milestone in the life sciences industry by being the first to successfully sequence polyclonal antibodies directly from proteins without DNA sequencing data. The team [...]
Kitchener Biotech Rapid Novor Raised $5M USD to Decode Immune System Rapid Novor Inc., the world's leader in antibody protein sequencing using mass spectrometry, announced today that it has secured a $5 million US dollar Series A round of financing led by Co-Win Venture. The investment will accelerate the company’s growth in technological and clinical [...]
How Rapid Novor is Responding to COVID-19 Our Commitment to Our Clients and Team Members Rapid Novor, Inc. recognizes the importance of maintaining the health and well-being of both our clients and dedicated team members. This is why we have incorporated additional health and safety protocols. These new protocols include mobilizing our team, [...]
Next Generation Protein Sequencing Company Rapid Novor Enters into New Phase of Growth Rapid Novor, Inc., the world's leader in antibody protein sequencing using mass spectrometry, is pleased to announce that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now home to four proteomics-grade mass spectrometers among other analytical instruments, the new [...]
Written by María Gerpe, Scientific Writer Meet Anthony: he likes having a quality meal. Balanced. With healthy fats like avocado. Anthony wakes up every morning to the smell of coffee and a strong sense of carpe diem. He doesn’t just employ the art of positive visualization, popularized by The Sopranos. His dogma, if a TV [...]
Rapid Novor Inc Expands Their Proteomics Lab and Welcomes the 3rd Mass Spectrometer Rapid Novor Inc., the world's leader in antibody protein sequencing using mass spectrometry, today announces the expansion of their mass spectrometry facility in Kitchener. With this expansion, the company tripled the laboratory footprints in order to host the newly installed Thermo Fisher [...]
Canadian Mass Spectrometry Veteran, Paul Taylor, Joins Rapid Novor Inc. Rapid Novor Inc., the world's leader in antibody protein sequencing using mass spectrometry, today announces that the Canadian mass spectrometry veteran, Mr. Paul Taylor has joined the team as the Core Facility Manager. Prior to joining Rapid Novor, Mr. Taylor has been the Manager and [...]
Dr. Thierry Le Bihan Joins Rapid Novor Inc. to Further Advance Antibody Protein Sequencing Technologies Rapid Novor Inc., the world's leader in antibody protein sequencing using mass spectrometry, today announces that Dr. Thierry Le Bihan has joined the team as a Senior Scientist. Prior to joining Rapid Novor, Dr. Le Bihan was a senior lecturer [...]
Rapid Novor Inc Announces Residency in JLABS @ Toronto Rapid Novor Inc, the world's leader in antibody protein sequencing using mass spectrometry, today announces that it becomes a resident company in Johnson & Johnson Innovation, JLABS @ Toronto, located in the MaRS Centre in Toronto, Canada. Rapid Novor Inc is a Kitchener-Waterloo based company dedicated [...]
At Rapid Novor, we constantly look for ways to deliver our REmAb™ service better, quicker and more consistent. We believe automation, both in the lab and in the data analysis platform, is crucial to meet our clients' ever evolving requirements on service throughput and quality. Today, we have our first pipetting robot from Opentrons installed [...]
Next-Generation Protein Sequencing – CEOCFO Magazine Interview with Rapid Novor Inc KITCHENER, Ontario, Aug. 22, 2017 /PRNewswire-iReach/ -- Rapid Novor Inc, the world leader in the next-generation protein sequencing, today announces that Mingjie Xie, the CEO of Rapid Novor Inc, has been interviewed by CEOCFO Magazine's Senior Editor Lynn Fosse. The interview, included in the [...]
Rapid Novor Opens Research Lab In Kitchener To Develop The Next-Generation Protein Sequencing Technology KITCHENER, Ontario, July 19, 2017 /PRNewswire-iReach/ -- Rapid Novor Inc, the world leader in next-generation protein sequencing, today announces that after six months of planning, setup and testing, its first proteomics grade mass spectrometry lab is now fully in operation. This [...]